Merck Manual

Please confirm that you are a health care professional

honeypot link

Childhood Vaccination Schedule


Michael J. Smith

, MD, MSCE, Duke University

Last full review/revision Nov 2021
Click here for Patient Education
Topic Resources

Practitioners should also check the CDC's latest recommendations (also available as a free mobile app), consult the CDC's child–adolescent immunization schedules and catch-up immunization schedule, and consult the relevant Advisory Committee on Immunization Practices (ACIP) statements for detailed recommendations and updates. Vaccination status should be reassessed at every visit.


COVID-19 vaccination in children

In addition to the immunizations noted in the immunization schedules, children in the US in certain age groups are now eligible for COVID-19 vaccination COVID-19 Vaccine COVID-19 vaccines provide protection against COVID-19. COVID-19 is the disease caused by infection with the SARS-CoV-2 virus. There are multiple COVID-19 vaccines currently in use worldwide... read more . The Pfizer-BioNTech COVID-19 vaccine (mRNA) has received an Emergency Use Authorization (EUA) for children 5 to 15 years of age and is approved for use in people 16 years of age and older. The Pfizer vaccine dose for ages 12 or older is 0.3 mL (30 mcg) IM, given in a 2-dose series 3 weeks apart. The Pfizer vaccine dose for ages 5 to 11 is 0.2 mL (10 mcg) IM, also given in a 2-dose series 3 weeks apart. EUA has also been granted for an additional dose, given at least 28 days after the second dose, for people 12 years of age and older who have certain immunocompromising conditions. COVID-19 vaccine may be given at the same time as routine immunizations.

  • Severe allergic reaction to a previous dose

  • Severe allergic reaction to a vaccine component

  • An immediate allergic reaction of any severity to a previous dose or known (diagnosed) allergy to a component of the vaccine

Polyethylene glycol (PEG) is used in mRNA vaccines and is the most commonly implicated allergen.

The Moderna COVID-19 vaccine (mRNA) is also being studied for use in children under 18 years of age but does not currently have approval or EUA.

COVID-19 vaccination in children reference

Malaria vaccination in children

On October 6, 2021, the World Health Organization (WHO) recommended widespread use of the RTS,S/AS01 (RTS,S) malaria vaccine among children in sub-Saharan Africa and in other regions with moderate to high Plasmodium falciparum malaria transmission. (See WHO recommends groundbreaking malaria vaccine for children at risk.)

More Information

Click here for Patient Education
NOTE: This is the Professional Version. CONSUMERS: Click here for the Consumer Version
Professionals also read
Test your knowledge
Mumps is an acute, contagious, systemic viral disease caused by a paramyxovirus. It is spread by droplets or saliva and probably enters through the nose and mouth. After a 12- to 24-day incubation period, headache, anorexia, malaise, and low-grade fever usually develop. Then several other symptoms develop over the next few days. Of these symptoms, edema of which of the following structures is most likely to peak on the 2nd day and typically last 5 to 7 days? 
Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID

Also of Interest